What was the primary driver of Intuitive Surgical's revenue growth in Q3 2011?

The primary drivers were increased sales of da Vinci Surgical Systems and strong growth in recurring revenue from instruments, accessories, and service contracts. The continued adoption of da Vinci procedures across various surgical specialties fueled this growth.

How is the company managing its expenses in relation to revenue growth?

Intuitive Surgical demonstrated effective expense management, with operating expenses growing at a slower rate (35% for operating income) than total revenue (30% for Q3 2011). This indicates operating leverage and improved profitability.

What is the company's financial position, particularly regarding cash and investments?

The company maintains a very strong financial position with $1.89 billion in cash, cash equivalents, and investments as of September 30, 2011. Operating activities generated robust cash flow, further strengthening its liquidity.

Are there any significant legal or regulatory risks highlighted in this report?

The report mentions ongoing class-action and derivative lawsuits related to past financial reporting. However, the company believes it has meritorious defenses and does not expect these to have a material adverse effect on its business. Additionally, the company notes potential disruptions from natural disasters, particularly mentioning the impact of the earthquake and tsunami in Japan.

ISRG 10-Q Quarterly Report Q3 FY2011 — Revenue, Net Income, EPS

Summary

Intuitive Surgical Inc. (ISRG) demonstrated robust financial performance in the third quarter of 2011, with total revenue growing 30% year-over-year to $446.7 million. This growth was driven by a significant increase in both system sales and recurring revenue from instruments, accessories, and services. The company successfully sold 133 da Vinci Surgical Systems, a 27% increase from the prior year, with the da Vinci Si model continuing to dominate sales. Recurring revenue accounted for 55% of total revenue, underscoring the strength of the company's ecosystem. Profitability also saw a healthy increase, with net income rising 41% to $122.4 million, or $3.05 per diluted share. This strong performance was supported by disciplined cost management, with operating expenses growing slower than revenue. The company maintained a strong balance sheet, ending the quarter with $1.89 billion in cash, cash equivalents, and investments, and generated substantial operating cash flow. Despite ongoing litigation, the company expressed confidence in its legal defenses and its ability to navigate potential outcomes without material adverse effects.

Financial Highlights

48 data points

Beta

Revenue

$446.70M

0.7% Gross Margin

Net Income

$122.40M

0.3% Net Margin

EPS (Diluted)

$0.34

Total Assets

$2.75B

Cash & Equivalents

$298.20M

Free Cash Flow

$157.60M

Financial Statements

Beta

Revenue	$446.70M
Cost of Revenue	$121.20M
Gross Profit	$325.50M
R&D Expenses	$35.40M
SG&A Expenses	$111.20M
Operating Expenses	$146.60M
Operating Income	$178.90M
Net Income	$122.40M
EPS (Basic)	$0.35
EPS (Diluted)	$0.34
Shares Outstanding (Basic)	351.90M
Shares Outstanding (Diluted)	360.90M

Key Highlights

1Total revenue increased by 30% to $446.7 million in Q3 2011 compared to Q3 2010.
2Net income grew by 41% to $122.4 million in Q3 2011.
3Diluted earnings per share increased to $3.05 in Q3 2011 from $2.14 in Q3 2010.
4133 da Vinci Surgical Systems were sold in Q3 2011, up 27% year-over-year.
5Recurring revenue (instruments, accessories, and service) grew 34% to $247.6 million and represented 55% of total revenue.
6The company's installed base of da Vinci Surgical Systems reached 2,031 as of September 30, 2011.
7Total assets increased to $2,746.0 million from $2,390.4 million at the end of 2010.

INTUITIVE SURGICAL INC Quarterly Report for Q3 Ended Sep 30, 2011

Summary

Financial Highlights

Key Highlights

Frequently Asked Questions